JP2002538219A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538219A5
JP2002538219A5 JP2000603708A JP2000603708A JP2002538219A5 JP 2002538219 A5 JP2002538219 A5 JP 2002538219A5 JP 2000603708 A JP2000603708 A JP 2000603708A JP 2000603708 A JP2000603708 A JP 2000603708A JP 2002538219 A5 JP2002538219 A5 JP 2002538219A5
Authority
JP
Japan
Prior art keywords
composition
adjuvant
growth factor
immunogenic peptide
peptide fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000603708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538219A (ja
Filing date
Publication date
Priority claimed from US09/266,543 external-priority patent/US6805865B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/006320 external-priority patent/WO2000053219A2/en
Publication of JP2002538219A publication Critical patent/JP2002538219A/ja
Publication of JP2002538219A5 publication Critical patent/JP2002538219A5/ja
Withdrawn legal-status Critical Current

Links

JP2000603708A 1999-03-11 2000-03-10 癌及び高増殖性疾患治療用の組成物及び方法 Withdrawn JP2002538219A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/266,543 US6805865B1 (en) 1993-05-27 1999-03-11 Compositions and methods for treating cancer and hyperproliferative disorders
US09/266,543 1999-03-11
PCT/US2000/006320 WO2000053219A2 (en) 1999-03-11 2000-03-10 Compositions and methods for treating cancer and hyperproliferative disorders

Publications (2)

Publication Number Publication Date
JP2002538219A JP2002538219A (ja) 2002-11-12
JP2002538219A5 true JP2002538219A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=23015010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000603708A Withdrawn JP2002538219A (ja) 1999-03-11 2000-03-10 癌及び高増殖性疾患治療用の組成物及び方法

Country Status (6)

Country Link
EP (1) EP1156824A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002538219A (cg-RX-API-DMAC7.html)
KR (1) KR20010102556A (cg-RX-API-DMAC7.html)
AU (2) AU776473C (cg-RX-API-DMAC7.html)
CA (1) CA2364503A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000053219A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814744B1 (fr) * 2000-10-04 2002-11-29 Commissariat Energie Atomique Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
ITRM20010088A1 (it) 2001-02-21 2002-08-21 Idi Irccs Peptide in grado di inibire l'attivita' del fattore di crescita derivato dalle piastrine (pdgf-bb) e del fattore di crescita derivato dai fi
US8021658B2 (en) 2001-05-25 2011-09-20 Thomas Jefferson University Alternative splice forms of proteins as basis for multiple therapeutic modalities
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
CU23178A1 (es) 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
KR100768265B1 (ko) * 2005-11-10 2007-10-17 한국화학연구원 혈액내 순환시간을 향상시키기 위한 헤파린이 수식된리포솜 및 이의 제조방법
CN105664147A (zh) * 2007-02-07 2016-06-15 日本电气株式会社 用于癌症的治疗剂
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
FR2990352A1 (fr) * 2012-05-10 2013-11-15 Univ Paris 13 Composition immunogene comprenant un peptide derive du vegf et ses utilisations
WO2020110154A1 (en) * 2018-11-30 2020-06-04 Bharat Biotech International Limited A chimeric therapeutic vaccine
CU24637B1 (es) 2019-12-24 2022-12-12 Ct Ingenieria Genetica Biotecnologia Polipéptidos que comprenden mutantes del vegf-a humano con re-arreglos de puentes disulfuro y composiciones que los contienen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0702563B1 (en) * 1993-05-27 2003-08-06 EntreMed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders
EP0657175B1 (en) * 1993-12-09 2005-03-02 Centro de Inmunologia Molecular Vaccine comprising human autologous epidermal growth factor and use thereof
JPH09316000A (ja) * 1996-05-31 1997-12-09 Toagosei Co Ltd 血管新生抑制用ワクチン
CA2310252A1 (en) * 1998-03-06 1999-09-10 Imclone Systems Incorporated Active immunization against angiogenesis-associated antigens

Similar Documents

Publication Publication Date Title
DE68917126T2 (de) T-zellen-epitope als träger für einen konjugierten impfstoff.
EP0658118B1 (en) Vaccines against group c neisseria meningitidis
ES2659050T3 (es) Procedimiento de conjugación para PNAG y una proteína transportadora
CA1335569C (en) Agents and procedures for provoking an immune response to gnrh and immuno sterilizing mammals
JP2001501640A (ja) ワクチン
JP2009132727A (ja) グループbストレプトコッカス・タイプiiおよびタイプv多糖−蛋白質接合ワクチン
JPH0832637B2 (ja) 合成免疫原
JP3365635B2 (ja) キトサン誘導性免疫強化
JPS60246321A (ja) 抗原性調製物および該調製物の単離法
CN103497255B (zh) 作为疟疾疫苗的恶性疟原虫表面蛋白的偶联物
CA2139217C (en) Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment
JP2004189751A (ja) 非細胞性(Acellular)百日咳ワクチン及びその調製方法
JP2007513992A (ja) 自己免疫疾患の治療用のil−12又はil−23を含むワクチン
JP2002538219A (ja) 癌及び高増殖性疾患治療用の組成物及び方法
TW201408322A (zh) 疫苗
MX2009001133A (es) Vacunas y metodos para controlar adiposidad.
AU624324B2 (en) Conjugate malaria vaccine
US4584195A (en) Broad spectrum vaccine against gonorrhea
AU668522B2 (en) Subunit vaccine for (neisseria meningitidis) infections and corresponding purified subunits
TWI811957B (zh) 重組多肽,包含該重組多肽的複合物,以及其用途
JP2021525754A (ja) じんましんの治療
JP2001518516A5 (cg-RX-API-DMAC7.html)
EP0975364B1 (en) Allergen formulation
JP2015525771A5 (cg-RX-API-DMAC7.html)
HRP20150612T1 (hr) Postupci i pripravci koji sadrže supramolekulske konstrukte